Goldman Sachs Put 32 FRE 21.02.20.../ DE000GJ7CNV2 /
23/01/2025 10:49:53 | Chg.- | Bid09:25:07 | Ask09:25:07 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.031EUR | - | 0.029 Bid Size: 100,000 |
0.036 Ask Size: 100,000 |
FRESENIUS SE+CO.KGAA... | 32.00 EUR | 21/02/2025 | Put |
GlobeNewswire
24/04/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23/04/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
23/02/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil